Heres the sort of announcement that came from TIS in nov 2018. I think the retina in a dish should at least take this off the table. As i said, how do you even get to phase 2 trial and have no idea the product doesn't work. Also shows ive picked my share of donkeys along with poh and obj lol.
Results Announcement: Phase 2 Clinical Trial of VF001 for Venous Leg Ulcer Healing Summary: • The Phase 2 trial of VF001 for the treatment of venous leg ulcer failed to meet all endpoints. • Analysis demonstrated no clinically meaningful or statistically significant difference in measures of wound healing, compared with placebo. • Ongoing development of VF001 for all indications halted. • Factor Therapeutics to limit further activity to maintaining existing intellectual property portfolio. • Investor conference call scheduled for 11.00 am AEST, Wednesday, November 14th, 2018. -------------------------------------------------------- Brisbane, Australia 14th November
PYC Price at posting:
5.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)